Markets:

Overview

News

Currencies

International

Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

22.16 -0.28 (-1.25%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge ↗

March 28, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Monday.

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

March 28, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....

Via Benzinga

Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views ↗

March 28, 2022

U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.

Via Benzinga

Recap: Immunome Q4 Earnings ↗

March 28, 2022

Immunome (NASDAQ:IMNM) reported its Q4 earnings results on Monday, March 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

58 Biggest Movers From Friday ↗

March 21, 2022

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)...

Via Benzinga

Benzinga's After-Hours Movers & News: Recruiter.com, Waitr Holdings And More ↗

March 11, 2022

Benzinga’s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...

Via Benzinga

FDA Lifts Clinical Hold on Immunome's COVID-19 Candidate IND ↗

March 11, 2022

The FDA has lifted the clinical hold on Immunome Inc's (NASDAQ: IMNM) Investigational New Drug (IND) application for its antibody cocktail (IMM-BCP-01) to...

Via Benzinga

76 Biggest Movers From Yesterday ↗

March 08, 2022

Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc...

Via Benzinga

Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus ↗

February 08, 2022

Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 12, 2022

On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...

Via Benzinga

The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗

January 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...

Via Benzinga

FDA Issues Clinical Hold On Immunome's COVID-19 Antibody Program ↗

January 11, 2022

Immunome Inc (NASDAQ: IMNM) has received an FDA clinical hold letter in response to its recently submitted IND requesting further information related to the...

Via Benzinga

21 Stocks Moving in Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...

Via Benzinga

The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case ↗

December 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...

Via Benzinga

Topics Intellectual Property

Why Are Immunome Shares Trading Higher Today? ↗

November 29, 2021

Immunome Inc (NASDAQ: IMNM) has submitted an Investigational New Drug (IND) application to the FDA for IMM-BCP-01, a three-antibody cocktail, for the treatment of COVID-19. IMM-...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021 ↗

October 29, 2021

Upgrades For Preferred Bank (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion....

Via Benzinga

54 Biggest Movers From Friday ↗

October 04, 2021

Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....

Via Benzinga

64 Biggest Movers From Yesterday ↗

October 28, 2021

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...

Via Benzinga

45 Stocks Moving In Monday's Mid-Day Session ↗

September 13, 2021

Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

Immunome's COVID-19 Antibody Neutralizes Two Variant Strains In Animal Studies ↗

September 07, 2021

Immunome Inc's (NASDAQ: IMNM) three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 21, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

July 21, 2021

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 21, 2021

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher ↗

July 20, 2021

Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has...

Via Benzinga

Topics Stocks

Dow Rises 500 Points as Rally Gains Momentum ↗

July 20, 2021

Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff.

Via Talk Markets

Topics Stocks

34 Stocks Moving In Tuesday's Mid-Day Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Immunome, Inc. - Common Stock (NQ:IMNM)

Headline News about Immunome, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today